Two vs three cycles of neoadjuvant sintilimab plus chemotherapy for resectable non-small-cell lung cancer: neoSCORE trial

Detalles Bibliográficos
Autores principales: Shao, Miner, Yao, Jie, Wang, Yunke, Zhao, Lufeng, Li, Baizhou, Li, Lili, Wu, Zuqun, Chen, Zexin, Fan, Junqiang, Qiu, Fuming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083171/
https://www.ncbi.nlm.nih.gov/pubmed/37032401
http://dx.doi.org/10.1038/s41392-023-01355-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083171/
https://www.ncbi.nlm.nih.gov/pubmed/37032401
http://dx.doi.org/10.1038/s41392-023-01355-1

Ejemplares similares